Clinical Trial Update: A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluated whether Lactobacillus CD2 lozenges can prevent high-dose chemotherapy-induced oral mucositis in patients undergoing hematopoietic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Lactobacillus CD2 Lozenges (Lactobacillus CD2)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Oral Mucositis | Phase 2 | Status: COMPLETED